Promising new research on aggressive breast cancer

Better treatments of HER2-positive breast cancer are closer at hand, thanks to new research by a team led by Université de Montréal professor Jean-François Côté at the cytoskeleton organization and cell-migration research unit of the UdeM-affiliated Montreal Clinical Research Institute. Published in PNAS, the journal of the U.S. National Academy of Sciences, the new research […]

Continue Reading